Primates In Medical Research Market - Forecast(2024 - 2030)

Primates In Medical Research Market Overview

The Primates In Medical Research Market size is estimated to reach $217.4 million by 2027. Furthermore, it is poised to grow at a CAGR of 2.3% over the forecast period of 2022-2027. Biomedical research has been a key aspect that is driving the use of nonhuman primates. Animal experimentations are performed widely on categories of mice, rats, fish, and various other animal models owing to their low sentience, and sub-par anatomic alignment with human physiology. Translational research activities are taken in the field to understand better cures or remedies, weighed against cost-benefit analysis. Primates have been extensively used owing to their similar physiological features, to that of humans. For example, diseases such as HIV present in human aligns with disease such as SIV which is prevalent in monkeys and affects the tissues, and molecules the same way HIV affects human cells. Furthermore, uproaring diseases such as PD or Parkinson's disease are being better understood owing to similar brain pathways of monkeys to humans. The growing concerns regarding various diseases along with heightened medical spending and patient need have been identified as the key driver for the Primates In Medical Research Industry for the projected period of 2022-2027.

Primates In Medical Research Market Report Coverage

The report: “Primates In Medical Research Market Forecast (2022-2027)”, by Industry ARC covers an in-depth analysis of the following segments of the Primates In Medical Research Market

Key Takeaways

Primates In Medical Research Market- Geography (%) for 2021.

For more details on this report - Request for Sample

Primates In Medical Research Market Segmentation Analysis- By Member

The primates In medical research market based on members can be further segmented into Apes, monkeys, and Others. Monkeys held a dominant market share in the year 2021. New world monkeys and old world monkeys are the common forms of lineage through which various medical research have been performed on. An important characteristic, which is organism pathogenicity makes monkeys a key medical specimen. A lot of micro-organisms do not affect mice/ mouse, the same they would affect the human class. However, primates such as monkeys or apes resemble close anatomy, specifically pertaining to the functioning of the immune system, which makes them an important class of test specimens.

Moreover, monkeys are estimated to be the fastest-growing, with a CAGR of 3.4% over the forecast period of 2022-2027. A quintessential reason for the same is the non-availability of vaccines for various diseases such as HIV/AIDS and Malaria. Medical researchers argue that millions of lives each year are lost owing to such pathogenic diseases, and hence, the cost-benefit analysis severely weighs for performing medical experiments on primates such as monkeys. As per WHO, in 2020, around 241 million cases of Malaria were prevalent worldwide, of which around 627,000 faced deaths due to the disease. To curb these numbers, monkeys as specimen would be highly used.

Primates In Medical Research Market Segmentation Analysis- By KRA (Key Research Area)

The primates In medical research market can be further segmented into KRA or Key Research Area into Parkinson’s Disease, Reproduction, Cognition, Vaccines, Vision, and Stroke. Vaccines held a dominant market share in the year 2021. It is owing to the large-scale trials which are/ were being held to combat the pandemic- COVID-19. The race for using primates as a vaccine trial began in 2004 when HIV/ AIDS took millions of lives. A similar form of the virus was being found in macaque monkeys- SIV (Simian Monkey Immunodeficiency, which attacked the same tissues and cells, and molecules that HIV affects in humans. Hence, various monkeys were being tested throughout 2020 and 2021 for COVID vaccines as large-scale clinical trials are extremely expensive, while pre-clinical research can find safe and effective vaccines. As of January 2022, around 50 vaccines are under phase-1 trial which tests efficacy and dosage in primates or non-human species.

Moreover, vaccines are estimated to be the fastest-growing, with a CAGR of 3.7% over the forecast period of 2022-2027. It is owing to the wide-scale need for finding plausible cures and remedies for human afflicted diseases, which can be successfully tested on primates to find immunogenetic response and safety.

Primates In Medical Research Market Segmentation Analysis-By Geography

The primates In medical research market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the rest of the world. North America held a dominant share of 38% as compared to the other regions in 2021. It is owing to vast-scale medical research activities which are partaken within the countries like the US. Further, the US spends around $4.1 trillion on medical well-being and infrastructure, one of the key attributes of such a high budget is better research and development funding activities. Around $5-10 billion are spent on R&D by the government. Additionally, giants such as Pfizer and Moderna received billions and spent billions to manufacture and research vaccines & medicines on primates.

However, Asia-Pacific is expected to offer lucrative growth opportunities to marketers in the projected period of 2022-2027. It is owing to the rising expenditure pertaining to research and development activities by countries such as China and India. India saw a 137% increase in its healthcare budget for 2021. Further, China spends exorbitant sums of money to find better-performing drugs and vaccines.

Primates In Medical Research Market Drivers

The growing applicational need for KRAs has been a key driver for the market.

KRAs or Key Research Areas have been widely studied owing to the far-fetched need to find cures and better medicinal modules for providing extended patient lives. For example, Parkinson's disease become extremely prevalent in the “growing-old” world. As per various studies, PD gets extremely prevalent with old age, and only 4% of PD patients are diagnosed before the age of 50. People with Parkinson’s disease have reduced levels of a substance called dopamine, which the brain uses to transmit information. This creates a disturbance in the part of the brain that controls movement, which leads to the trembling and loss of muscular control found in Parkinson’s. As per Parkinson’s foundation, around 10 million people worldwide are living with PD, of which around 1 million reside within the U.S. Further, brain pathways for the control of movements are extremely similar for the monkey and humans- which makes them a topic/module for study.

A close resemblance of primates with humans on anatomical grounds has allowed the market to grow.

Ideally, primates would not have to be used in medical research. They are used only when no satisfactory alternatives exist – in other words, when there is no other way to advance knowledge in an essential area of medical science or to be as sure as possible that new treatments for serious diseases are safe to test on humans. Some of the key areas/ problems faced by humans, which were eliminated by the use of primates are the existential development of polio vaccines, life support systems for premature babies, kidney dialysis, surgical treatment for macular degeneration, asthma combatting drugs, and many others. Over 110 million children were vaccinated on Polio National Immunisation Day in India. Similarly, around 15 million babies each year are born pre-term. Asthma has been becoming a concern amongst the world community owing to large-scale globalization and heightened pollution. As per WHO, around 262 million people were diagnosed with the said condition in 2019. All of the research was successful owing to the close resemblance of primates such as monkeys with humans, and certainly, a whole range of use has been left beyond bounds.

Primates In Medical Research Market Challenges

Concerns pertaining to the conscious use of primates along with high red-tapisms to obtain structural/ test licenses have impeded the market growth

A key principle of research involving animals is that the least sentient species possible should be used. ‘Sentience’ refers to an animal’s conscious awareness of the world and itself. Although it is impossible to know about the conscious experience of other animals, the general consensus is that the level of sentience varies between animals; there is no clear distinction between being sentient and being non-sentient. However, mouse/mice are considered to be the least sentient animal category, which allows them to be used in medical research. Additionally, ethical issues such as “cost-benefit analysis” must be performed to ascertain the use of such animals. Within the said analysis, the cost of animal experience is weighed against the benefits of humankind. Within the said norm, the latter’s importance is felt highly. Furthermore, to be able to use primates, a researcher will have to demonstrate to four bodies that primate use is justified: the institute in which they work, a research ethics committee, the Home Office, and the source of research funds.

Primates In Medical Research industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Primates In Medical Research Market. Top-10 Primates In Medical Research Market key companies are-

1. Charles River Laboratories,
2. The Jackson Laboratory,
3. GenOway S.A.,
4. Taconic Biosciences, Inc.,
5. Envigo,
6. PerkinElmer, Inc.
7. JSR Corporation
8. Pfizer Inc.
9. Merck Group
10. GlaxoSmithKline
    

Recent Developments

• In January 2022, independent research was conducted to identify the host genetic variants associated with COVID-19, which play a part in influencing the disease severity. The variants are located at non-coding regions- the said can affect the expression of neighboring genes. Hence, CRISP-I interference-mediated gene expression analysis was performed, and the expression was investigated using COVID-10 contracted human and monkey lung single-nucleus/cell RNA seq-data sets. The study was funded by NIH.
• In December 2021, A monkey breeding facility north of MESA is now under investigation by the FEDS owing to concerns regarding animals being mistreated and dying as a result of it. The facility is run by the University of Washington on Salt River Pima-Maricopa. OLAW- Office of Lab Animal Welfare has opened an investigation in the Center. USDA records show monkeys have died from dehydration, a lack of fasting before surgery, and strangulation on an enrichment device.
• In July 2021, the US has been boosting funding for research on monkeys in the wake of COVID. The entire goal of the same is to lower the shortage of this animals-which have grown short in 2020 as scientists have had tested scores of COVID-19 vaccines on primates and treatments before the trials even began in people. The NIH has invested about $29 million in the last two years. The said investment resulted in building better housing-outside enclosures- and various other infrastructural improvements at US NPRc. Additionally, the agency is expected to spend another $7.5 million by October. If the budget gets approved by US Congress, the NPRCs can see an allotment of $30 million in the next fiscal.

Relevant Titles